Skip to main content
NIH funding notice PAR-22-219

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Closed on November 19, 2024.

Posted
July 26, 2022
Close date
November 19, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $682,962 in first-year total cost, median $232,286.

Most frequent study sections

  1. Cancer Genetics Study Section[CG]1
  2. Environmental Determinants of Disease Study Section [EDD]1
  3. Special Emphasis Panel[ZRG1 TIO-D (01)]1

Most frequent institutions

  1. DARTMOUTH COLLEGE1
  2. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  3. WASHINGTON UNIVERSITY1
Competing awards under PAR-22-219 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Cellular and Molecular Mechanisms of Arsenic-Induced Urothelial Bladder Cancer1R21CA290425-01LEACH, STEVEN DDARTMOUTH COLLEGE, NH$232,286EDD
2023Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)1R21CA274148-01A1HOROWITZ, AMIRSFAKIANOS, JOHNICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$237,023ZRG1
2023Androgen and Wnt signaling in bladder cancer1R21CA283677-01MA, LIANGWASHINGTON UNIVERSITY, MO$213,653CG

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-22-219: Biology of Bladder Cancer (R21 Clinical Trial Optional) | ScienceDex | ConductScience